| Literature DB >> 35049787 |
Janeen L Salak-Johnson1,2, Cassidy Reddout1, Lily Hernandez1, Anne Visconti2.
Abstract
The study aimed to investigate and characterize the maternal effects of feeding Saccharomyces cerevisiae var. boularddii (Scb) to sows from late-gestation through lactation on progeny cortisol, immune status, and stress responsiveness from birth to 14 days post-weaning. Eighty-four piglets were born to sows fed control (CON) or probiotic (PRO) boluses twice daily for 59 days. Blood samples were obtained at birth and 24 h later to assess prenatal effects; 7, 14, and 21 day-of-age to assess potential developmental effects; and at 24 h, 7, and 14 days post-weaning to assess the effects of weaning stress on immune and cortisol responses. Pigs born to PRO sows had less robust cortisol response and enhanced immune parameters at birth and 24 h later, indicating less stress. In response to weaning, pigs born to and nursed by PRO sows displayed unique cortisol and immune profiles than CON pigs. These results indicate that feeding sows Scb probiotics during late gestation reduces stress responsiveness to farrowing stress while increasing immune cell populations. Pigs nursed by PRO sows had a more robust initial cortisol response and enhanced neutrophil function and B-cell lymphocyte proliferation in response to weaning stress. These data imply it may be possible to maternally alter immune and stress responses in utero and during suckling in the short-term and up to 14 days post-weaning. However, more research is needed to optimize this strategy.Entities:
Keywords: chemotaxis; cortisol; lymphocyte proliferation; natural killer cell cytotoxicity; neonates; phagocytosis; stress; weaning; yeast-probiotic
Year: 2022 PMID: 35049787 PMCID: PMC8772566 DOI: 10.3390/ani12020164
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Figure 1Effect of prenatal maternal treatment on plasma cortisol concentrations (left) and percentage of neutrophils (right) of piglets at birth and 24-h later. Data are expressed as means ± SEM, and means with different letters differ at p < 0.05 (treatment × day of age).
Prenatal maternal gestational treatment effects on the progeny mean plasma cortisol, total white blood cell counts, leukocyte differentials, neutrophil-to-lymphocyte ratio, and interleukin-12 at birth (prior to suckling) 1,2.
| Measures | Control | Probiotic | SEM | |
|---|---|---|---|---|
| Plasma cortisol, ng/mL | 205.8 | 111.1 | 9.21 | <0.000 |
| White blood cell, 107/10 µL | 1.67 | 2.37 | 0.180 | 0.006 |
| Lymphocytes, % | 47.1 | 38.9 | 1.09 | 0.002 |
| Neutrophils, % | 51.5 | 59.0 | 1.17 | 0.004 |
| Monocytes, % | 0.98 | 1.57 | 0.180 | 0.019 |
| Eosinophils, % | 0.44 | 0.29 | 0.073 | 0.149 |
| Neutrophil-to-lymphocyte ratio | 1.16 | 1.84 | 0.122 | <0.001 |
| Interleukin-12 pg/mL | 172.4 | 170.0 | 9.15 | 0.736 |
1 Data are shown as least squares means ± standard error of mean (SEM) (n = 42 piglets per sow treatment). 2 Gestational treatments were control = sugar-based placebo and probiotics = Saccharomyces cerevisiae var. boulardii.
Prenatal maternal gestational treatment effects on the progeny mean plasma cortisol, white blood cell counts, leukocyte differentials, neutrophil-to-lymphocyte ratio, and interleukin-12 at 24 h post-birth 1,2.
| Measures | Control | Probiotic | SEM | |
|---|---|---|---|---|
| Plasma cortisol, ng/mL | 119.0 | 75.1 | 6.20 | <0.000 |
| White Blood Cell, 107/10µL | 2.03 | 2.51 | 0.142 | 0.019 |
| Lymphocytes, % | 37.6 | 32.2 | 1.20 | <0.005 |
| Neutrophils, % | 60.6 | 64.6 | 1.02 | 0.023 |
| Monocytes, % | 1.31 | 2.11 | 0.182 | 0.002 |
| Eosinophils, % | 0.46 | 0.51 | 0.078 | 0.626 |
| Neutrophil-to-lymphocyte ratio | 2.34 | 2.62 | 0.285 | 0.507 |
| Interluekin-12, pg/mL | 183.5 | 190.1 | 7.49 | 0.531 |
1 Data are shown as least-square means ± standard error means (SEM) represents n = 42 piglets per sow treatment. 2 Gestational treatments were controls = sugar-based placebo and probiotics = Saccharomyces cerevisiae var. boulardii.
Interactive effects of maternal treatment on the progeny’s mean plasma cortisol and descriptive and functional immune measures during the suckling phase at 7, 14, and 21 days of age (before weaning) 1,2.
| 7D | 14D | 21D | ||||||
|---|---|---|---|---|---|---|---|---|
| Measures | Control | Probiotic | Control | Probiotic | Control | Probiotic | SEM | Treatment × Age |
| Plasma cortisol, ng/mL | 43.4 | 42.4 | 37.1 | 45.6 | 44.2 | 50.8 | 6.00 | 0.493 |
| White blood cell, 107/10 µL | 6.29 | 6.10 | 3.49 | 3.34 | 1.41 | 2.24 | 0.70 | 0.697 |
| Lymphocyte, 107/mL | 3.96 a | 4.86 a | 3.70 a | 4.68 a | 8.94 b | 4.03 a | 2.01 | 0.005 |
| Neutrophil, 106/mL | 4.43 | 3.86 | 2.49 | 2.71 | 2.64 | 2.04 | 0.53 | 0.432 |
| Lymphocytes, % | 43.9 a | 53.0 b | 60.4 c | 64.4 cd | 65.7 d | 65.4 cd | 2.23 | 0.060 |
| Neutrophils, % | 53.7 a | 44.4 b | 37.4 c | 32.7 c | 33.0 c | 32.5 c | 2.25 | 0.088 |
| Monocytes, % | 2.47 a | 2.20 ab | 1.88 a | 1.17 ad | 1.69 ac | 2.13 ab | 0.43 | 0.165 |
| Eosinophils, % | 0.27 | 0.40 | 0.46 | 0.53 | 0.42 | 0.36 | 0.13 | 0.758 |
| Neutrophil-to-lymphocyte ratio | 1.62 a | 0.97 b | 0.69 c | 0.61 c | 0.57 c | 0.61 c | 0.11 | 0.001 |
| Chemotaxis-C5a, no./5 fields | 31.2 a | 31.6 a | 39.9 a | 68.2 b | 110.2 c | 115.4 c | 4.94 | 0.052 |
| Chemotaxis- IL8, no./5 fields | 34.9 a | 32.1 a | 56.3 b | 84.6 c | 125.1 d | 92.4 c | 6.21 | 0.007 |
| Neutrophil phagocytosis, % | 67.4 ab | 68.7 a | 63.4 ab | 61.1 bc | 56.0 c | 62.2 b | 3.09 | 0.036 |
| Natural killer cell cytotoxicity, % | 54.9 | 53.4 | 58.6 | 66.9 | 49.7 | 67.7 | 7.81 | 0.605 |
| Concanavalin-A proliferation | 1.02 a | 1.25 ab | 1.18 ab | 1.27 ab | 2.47 c | 1.75 d | 0.12 | 0.053 |
| Lipopolysaccharide proliferation | 1.39 a | 1.76 b | 1.31 a | 1.14 c | 1.46 a | 1.72 b | 0.20 | 0.067 |
| Interleukin-12, pg/mL | 165.6 | 158.1 | 259.7 | 276.8 | 296.3 | 317.6 | 17.95 | 0.425 |
1 Data are shown as least-squares mean ± pooled standard error mean (SEM) represents n = 42 piglets per sow treatment. a–d Within a row, means without a common superscript letter differ at p ≤ 0.05, the p-value is the interactive effect of sow treatment × piglet age (Treatment × Age). 2 Sow treatments were controls = sugar-based placebo and probiotics = Saccharomyces cerevisiae var. boulardii. 7D = 7 days-of-age; 14D = 14 days-of-age; 21D = 21 days-of-age.
Interactive effects of maternal treatment by days post-weaning on pig plasma cortisol and descriptive and functional immune measures in response to weaning stress 1,2.
| D0 | D1 | D7 | D14 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Measures | Control | Probiotic | Control | Probiotic | Control | Probiotic | Control | Probiotic | SEMp | Treatment × Day |
| Plasma cortisol, ng/mL | 44.4 a | 50.8 a | 36.4 b | 53.3 a | 24.7 c | 31.1 bc | 25.8 c | 25.1 c | 4.00 | 0.023 |
| White Blood Cell (WBC), 108/mL | 1.41 a | 2.21 a | 2.19 a | 1.35 b | 2.30 b | 2.08 ab | 3.37 c | 3.51 c | 0.28 | <0.001 |
| Lymphocyte, 107/mL | 8.94 a | 4.03 b | 3.44 bc | 1.58 c | 3.80 b | 2.51 bc | 5.25 b | 3.72 b | 1.31 | 0.052 |
| Neutrophil, 106/mL | 2.64 a | 2.04 a | 1.76 a | 1.64 a | 2.26 a | 2.02 a | 7.29 b | 5.13 c | 0.47 | 0.061 |
| Lymphocytes, % | 65.7 | 65.2 | 56.1 | 57.5 | 59.0 | 61.0 | 47.7 | 56.3 | 2.40 | 0.143 |
| Neutrophils, % | 33.0 | 32.1 | 41.1 | 39.6 | 37.1 | 33.9 | 49.7 | 40.9 | 2.51 | 0.196 |
| Monocytes, % | 1.69 | 2.13 | 2.54 | 2.44 | 3.04 | 3.92 | 1.71 | 1.87 | 0.59 | 0.504 |
| Eosinophils, % | 0.41 | 0.35 | 0.38 | 0.30 | 0.52 | 1.04 | 0.96 | 0.87 | 0.15 | 0.116 |
| Neutrophil-to-lymphocyte ratio | 0.57 a | 0.60 a | 0.85 b | 0.87 b | 0.72 ab | 0.63 a | 1.23 c | 0.81 b | 0.10 | 0.012 |
| Chemotaxis-C5a, no. | 110.2 | 115.4 | 60.1 | 64.5 | 75.3 | 58.3 | 67.8 | 64.1 | 13.2 | 0.858 |
| Chemotaxis-IL-8, no. | 125.1 a | 92.4 b | 118.8 a | 143.8 c | 65.0 d | 66.7 d | 113.4 a | 173.1 e | 9.3 | 0. 053 |
| Neutrophil phagocytosis, % | 56.0 a | 62.3 b | 70.1 c | 65.3 bc | 60.5 b | 62.3 b | 66.2 c | 68.3 c | 1.91 | <0.008 |
| Natural killer cell cytotoxicity, % | 49.7 | 67.7 | 33.2 | 35.7 | 70.7 | 71.5 | 47.7 | 45.0 | 5.75 | 0.237 |
| ConcanavalinA proliferation | 2.47 a | 1.75 b | 1.72 b | 2.32 a | 2.36 a | 2.43 a | 2.18 ab | 2.06 ab | 0.23 | 0.021 |
| Lipopolysaccharide proliferation | 1.45 ab | 1.72 a | 1.65 a | 1.89 a | 1.10 b | 1.63 a | 1.65 a | 3.07 c | 0.38 | 0.072 |
| Interluekin-12, pg/mL | 296.3 | 317.4 | 230.0 | 258.7 | 419.3 | 411.8 | 312.9 | 353.5 | 23.7 | 0.312 |
1 Data are shown as least-squares means ± pooled standard error means (SEMp) represents n = 42 piglets per sow treatment. a–e Within a row, means with different superscript differ at p < 0.05, p-value is the interactive effect of sow treatment × day post-wean (Treatment × Day). 2 Sow treatments were controls = sugar-based placebo and probiotics = Saccharomyces cerevisiae var. boulardii. Days (D) post-weaning are represented as 0D = prior to weaning, 1D = 24 h post-wean, 7D = 7 days post-wean, and 14D = 14 days post-wean.
Figure 2Body weights for pigs born to sows individually fed either control (sugar-based placebo) or probiotic (Saccharomyces cerevisiae var. boulardii) boluses from late-gestation through the end of lactation.